AUPQ084899A0 - Neurotrophin agonists - Google Patents

Neurotrophin agonists

Info

Publication number
AUPQ084899A0
AUPQ084899A0 AUPQ0848A AUPQ084899A AUPQ084899A0 AU PQ084899 A0 AUPQ084899 A0 AU PQ084899A0 AU PQ0848 A AUPQ0848 A AU PQ0848A AU PQ084899 A AUPQ084899 A AU PQ084899A AU PQ084899 A0 AUPQ084899 A0 AU PQ084899A0
Authority
AU
Australia
Prior art keywords
neurotrophin
agonists
neurotrophin agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ0848A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Priority to AUPQ0848A priority Critical patent/AUPQ084899A0/en
Publication of AUPQ084899A0 publication Critical patent/AUPQ084899A0/en
Priority to JP2001502457A priority patent/JP2003502295A/en
Priority to CA002376729A priority patent/CA2376729A1/en
Priority to AU49016/00A priority patent/AU780408B2/en
Priority to EP00930886A priority patent/EP1212353A4/en
Priority to PCT/AU2000/000641 priority patent/WO2000075176A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AUPQ0848A 1999-06-08 1999-06-08 Neurotrophin agonists Abandoned AUPQ084899A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPQ0848A AUPQ084899A0 (en) 1999-06-08 1999-06-08 Neurotrophin agonists
JP2001502457A JP2003502295A (en) 1999-06-08 2000-06-07 Small cyclic mimic of brain-derived neurotrophic factor
CA002376729A CA2376729A1 (en) 1999-06-08 2000-06-07 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
AU49016/00A AU780408B2 (en) 1999-06-08 2000-06-07 Small cyclic mimics of brain-derived neurotrophic factor (BDNF)
EP00930886A EP1212353A4 (en) 1999-06-08 2000-06-07 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
PCT/AU2000/000641 WO2000075176A1 (en) 1999-06-08 2000-06-07 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ0848A AUPQ084899A0 (en) 1999-06-08 1999-06-08 Neurotrophin agonists

Publications (1)

Publication Number Publication Date
AUPQ084899A0 true AUPQ084899A0 (en) 1999-07-01

Family

ID=3815045

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ0848A Abandoned AUPQ084899A0 (en) 1999-06-08 1999-06-08 Neurotrophin agonists

Country Status (5)

Country Link
EP (1) EP1212353A4 (en)
JP (1) JP2003502295A (en)
AU (1) AUPQ084899A0 (en)
CA (1) CA2376729A1 (en)
WO (1) WO2000075176A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783683B2 (en) 2000-01-18 2005-11-24 Vegenics Limited VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor
TWI234460B (en) * 2002-04-03 2005-06-21 Purzer Pharmaceutical Co Ltd Cyclic pentad-peptide and its preparing method
RU2410392C2 (en) 2009-02-16 2011-01-27 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН Dipeptide mimetics of ngf and bdnf neurotrophins
KR101138048B1 (en) 2009-11-06 2012-04-23 성균관대학교산학협력단 Novel peptides upregulating BDNF expression and pharmaceutical composition for protection and therapy against Alzheimer's disease and Parkinson's disease comprising the same
RU2477144C2 (en) * 2010-03-22 2013-03-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук Drug preparation with antiarrhythmic and antifibrillatory action
RU2613314C2 (en) * 2013-06-28 2017-03-15 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Small molecules with ngf-like activity and antidiabetic properties
CA3126917A1 (en) * 2019-01-14 2020-07-23 New York University Cyclic peptide dimers
EP4180446A1 (en) * 2020-07-10 2023-05-17 The University of Tokyo Cyclic peptide, peptide complex, and drug composition containing said cyclic peptide and/or said peptide complex

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
JPH04124198A (en) * 1990-09-12 1992-04-24 Sumitomo Pharmaceut Co Ltd Neurotropic peptide derivative
US5571787A (en) * 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
JPH10212241A (en) * 1996-05-27 1998-08-11 Sumitomo Pharmaceut Co Ltd Preparation stably containing bdnf
JPH1156386A (en) * 1997-08-08 1999-03-02 Sumitomo Pharmaceut Co Ltd Regeneration of recombinant bdnf
CZ2001655A3 (en) * 1998-08-28 2001-11-14 Myelos Corporation Cyclic peptide, preparation containing thereof, myelination induction method, method of suppressing neuron degeneration and treatment method

Also Published As

Publication number Publication date
EP1212353A4 (en) 2004-10-20
JP2003502295A (en) 2003-01-21
WO2000075176A1 (en) 2000-12-14
EP1212353A1 (en) 2002-06-12
CA2376729A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU1554301A (en) Radioprotecting agent
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU6440900A (en) Homogentisate-dioxygenase
AUPQ084899A0 (en) Neurotrophin agonists
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU3191100A (en) Ligand-bonded complex
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU7303400A (en) Osseo-distractor
AU1915601A (en) Periotome
AU7513400A (en) Hydantoin-racemase
AU2582200A (en) Windturbine
AU4435300A (en) Hula-hoop
AU5416100A (en) Retinoscopes
AU2197301A (en) Microlamp
AU1737601A (en) Collectalbum

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4901600

Country of ref document: AU